In an effort to understand the language of the immune system, I developed a Markov model for monitoring within-sequence information content and entropic shifts of patient immune repertoires and for feature selection of clonotype characteristics dominant in disease response to IL-2 treatment of renal tumors. Manuscript in Preparation.